Metabolic effects associated with atypical antipsychotic treatment in the developmentally disabled.

@article{McKee2005MetabolicEA,
  title={Metabolic effects associated with atypical antipsychotic treatment in the developmentally disabled.},
  author={Jerry R. McKee and James W. Bodfish and Steven L Mahorney and William L Heeth and Melissa P Ball},
  journal={The Journal of clinical psychiatry},
  year={2005},
  volume={66 9},
  pages={1161-8}
}
OBJECTIVE Atypical antipsychotics, especially clozapine and olanzapine, have been increasingly associated with weight gain and other adverse metabolic events (diabetes mellitus, hyperlipidemia) in non-mentally retarded populations. This report explores the incidence of this phenomenon in an institution-dwelling population of individuals with developmental… CONTINUE READING